Pilot trial of interleukin-2 with granulocyte colony Stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
Journal of Clinical Oncology.
Times cited: 26
- Il-2 plus g-csf as a mobilization regimen in advanced breast cancer patients receiving high dose chemotherapy: marked expansion of activated t and nk cells with enhanced cytolyt1c activity within the autograft, without compromise of the hematologic engraftment. Experimental Hematology. 1998 Academic Article